title: L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients.
authors.affiliation: Department of Neurology, Mt. Sinai Medical Center, City University of New York, New York.
authors.forename: T S
authors.initials: TS
authors.lastname: Elizan
authors.forename: M D
authors.initials: MD
authors.lastname: Yahr
authors.forename: D A
authors.initials: DA
authors.lastname: Moros
authors.forename: M R
authors.initials: MR
authors.lastname: Mendoza
authors.forename: S
authors.initials: S
authors.lastname: Pang
authors.forename: C A
authors.initials: CA
authors.lastname: Bodian
mesh_terms: D000368:Aged; D002230:Carbidopa / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*; D011446:Prospective Studies; D012642:Selegiline / Q000008:administration & dosage*
chemical_list: D012642:Selegiline; D007980:Levodopa; D002230:Carbidopa